|
ALEC
|
Alector, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
0.05%
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
0.05%
|
US
|
NYSE
|
|
ZYME
|
Zymeworks Inc.
|
0.04%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.04%
|
US
|
NASDAQ
|
|
STRO
|
Sutro Biopharma, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
|
QTRX
|
Quanterix Corporation
|
0.04%
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
0.04%
|
US
|
NYSE
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.04%
|
US
|
NASDAQ
|
|
MXCT
|
MaxCyte, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
FULC
|
Fulcrum Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
EWTX
|
Edgewise Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|